Morgan Levine

Background

Morgan Levine trained in gerontology and biostatistics. Faculty at Yale School of Medicine before joining Altos Labs.

Key contributions

• PhenoAge — a clinical-biomarker biological-age score from 9 standard lab values, predictive of all-cause mortality.
• DNAm-PhenoAge — projects PhenoAge onto DNA methylation data; the first “second-generation” epigenetic clock trained on phenotypes rather than chronological age.
• PCPhenoAge / PCGrimAge — principal-component versions that reduce measurement noise.
• Work on epigenetic aging trajectories, intervention response, and cancer-incidence prediction.

Public communication

Authored True Age (2022), a popular book on biological age. Active public communicator on biological-age interpretation.

Now

Joined Altos Labs in 2022. Continues work on biomarker-based biological age and intervention-trial endpoints.

Related entries

PhenoAge, Epigenetic clocks, Steve Horvath.